In May, as Andrew B. Bindman, MD, began his tenure as director of the Agency for Healthcare Research and Quality (AHRQ), the agency had recently survived the threat of a congressional spending bill for fiscal year (FY) 2016 that proposed to eliminate its funding. Although AHRQ endured, it was with a substantial budget cut, from $364 million to $334 million. As of press time, the agency was waiting to see if a proposed cut for FY 2017 that would decrease its discretionary budget by 16% would be in the final bill.
Stephenson J. AHRQ Director Sets Course for Agency’s Health Services Research. JAMA. 2016;316(16):1632-1634. doi:10.1001/jama.2016.12702